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The present study was designed to examine the absorption, distribution, and metabolic effects of cholestanol on the hepatic rate-controlling enzymes of cholesterol and bile acid synthesis. Alterations in the hepatic ultrastructure related to the administration of cholestanol and cholesterol were also investigated. Animals and diets Sprague-Dawley male rats of initial body weight of 130-150 g were kept individually in metabolism cages to prevent coprophagy. They were fed a stock diet consisting of ground Purina rat chow (5001) supplemented with 5% corn oil. This diet contained 0.014% cholesterol, 0.034% plant sterols, and only trace amounts of cholestanol. When were added to this diet at a level of 2%. The sterols were incorporated into the diets from an ether solution as described previously (6) . The rats were fed the diets and drinking water ad lib. for 14 d. Weight and food intake were recorded daily, and any animal that differed by >10% from the average of the control group was excluded from the study.
Experimental design
Three groups of rats (five animals in each group) were fed (a) control diet, (b) diet supplemented with 2% cholestanol, and (c) diet supplemented with 2% cholesterol. At the end of the experimental period the animals were anesthetized with sodium pentobarbital (Fort Dodge Laboratories, Inc., Fort Dodge, IA). The common bile duct was cannulated and bile was collected for a period of 30-60 min. In addition, blood samples were taken from each animal. The rats were then killed by exsanguination and the livers were excised, weighed, and prepared for sterol, enzymatic, and histologic evaluation. Measurements were carried out to determine HMG-CoA reductase and cholesterol 7a-hydroxylase activity, biliary, fecal, serum, and hepatic sterol concentrations, and biliary bile acid composition.
In addition, two groups of rats were treated with cholesterol or cholestanol as described above, with the exception that after 2 wk the rats were given an oral tracer dose of [1,2- GLC. Cholesterol and cholestanol were analyzed and quantitated by GLC on 180 X 0.4-cm columns packed with SP-1000 (Applied Science Laboratories, Inc., State College, PA). Column temperature was 220'C, and N2 flow 30 ml/min (model 5840A gas chromatograph, Hewlett Packard Co., Palo Alto, CA). The retention times, relative to Sa-cholestane (7.31 min), were cholesterol, 7 .11 and cholestanol, 6.19 . Bile acids were determined as the trimethylsilyl-ether methyl derivatives on Hi-EFF 8BP columns (Applied Science Laboratories), column temperature was 240'C, and N2 flow 35 ml/min. The retention times, relative to 5a-cholestane (3.2 min), were: cholic acid, 1.53; chendeoxycholic acid, 2.54; allocholic acid, 1.27; and allochendeoxycholic acid, 2.07.
Mass spectra. Mass spectra of the bile acids were obtained with a Varian MAT-III gas chromatograph-mass spectrometer (Varian Associates, Palo Alto, CA) at an ion source pressure of 2-3 X 10-6 mm and an electron energy of 70 eV, as described previously (14).
Methods
Determination of biliary sterols and bile acids. Biliary sterols and bile acids were isolated, identified, and quantitated by a combination of TLC and GLC-mass spectroscopy, as described previously (15, 16) .
Fecal sterol and bile acid analysis. Feces and intestinal contents 1. Abbreviations used in this paper: GLC, gas-liquid chromatography; HMG CoA, hydroxymethylglutaryl-coenzyme A; TLC, thin-layer chromatography. The following systematic names are given to compounds referred to by trivial names: cholesterol, 5-cholesten-3fl-ol; cholestanol, 5a-cholestan-3,B-ol; coprostanol, 5j-cholestan-33-ol; 7a-hydroxycholesterol, 5-cholesten-3f3,7a-diol; ,B-sitosterol, 24j-ethyl-5-cholesten-30-ol; cholic acid, 3a,7a, 12a-trihydroxy-5/1-cholanoic acid; f-muricholic acid, 3a,6fB,73-trihydroxy-5#-cholanoic acid; allocholic acid, 3a,7a,12a-trihydroxy-Sa-cholanoic acid; allochenodeoxycholic acid, 3a,7a-dihydroxy-5a-cholanoic acid.
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were pooled, dried, and extracted with ethanol in a Soxhlet extractor for 48 h. After separation of the acidic steroids from the neutral ones, saponification under pressure, extraction, and methylation (17) bile acid composition was determined by GLC. Serum sterol analysis. 1 vol of serum (0.1-0.5 ml) was diluted with 9 vol of 0.1 M NaOH in 0.9% NaCl and percolated through a column of Amberlite XAD-2 (Servachrom XAD-2, 100-200 lsm, Serva, Heidelberg, Federal Republic of Germany) (18) . The eluate was evaporated and sterol concentrations were determined by GLC.
Cholesterol determination in hepatic microsomes. Known aliquots of microsomal suspensions were refluxed for 3 h with 25% ethanolic KOH (19) . Cholesterol and cholestanol were extracted with n-hexane and analyzed by GLC using Sa-cholestane as internal standard as described in "Experimental Procedures".
Determination offree and esteriJied sterols in the liver. The lipids in I ml liver homogenate were extracted in 20 ml of chloroform/ methanol, 2:1 (I 1). The solvent was evaporated and the lipid residue was divided into two portions. Free sterols were determined by GLC, while total sterol content was determined in the same manner after alkaline hydrolysis ( 19) . The percent of esterified sterols was calculated from the difference of these two values.
Histology. For light microscopic examination, buffered formalinfixed and paraffin-embedded 6-,um-thick sections of liver specimens were stained with hematoxylin and eosin and with other special stains such as Masson's trichrome for connective tissue. For electron microscopic studies, small pieces of the liver were fixed in ice-cold s-collidine-buffered 1% osmium tetroxide. After dehydration through a series of graded concentrations of alcohol, they were embedded in Enzyme assays. The remainder of the liver tissue (kept at 00-50C) was used immediately for preparation of the microsomal fraction. In order to eliminate as far as possible variation due to the diurnal rhythm of enzyme activity, all animals were killed by 9 to 11 a.m., i.e., during the diurnal minimum (23, 24) . The specific activity of hepatic microsomal hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase was determined in the presence of NaF exactly as described by Rodwell et al. (25) . The specific activity of cholesterol 7a-hydroxylase was determined in acetone powder preparations obtained from the microsomal fractions and contained virtually no endogenous cholesterol (19) .
Results
Hepatic sterol content. Table I shows the effect of cholestanol and cholesterol feeding on hepatic sterol concentration. When a diet that contained 2% cholestanol was fed there was a 48% increase in total sterol concentration (3.26 ± 0.2 vs. 2.2 ± 0.17 mg/g liver; P < 0.00001). The rise in hepatic sterols was entirely accounted for by the deposition of absorbed dietary cholestanol and was associated with a small decline in hepatic cholesterol content. The cholestanol content increased 35-fold from 0.04 ± 0.003 to 1.40 ± 0.09 mg/g liver. When a diet that contained 2% cholesterol was fed, total hepatic sterol concentration increased fourfold over control (8.66 ± 0.4vs. 2.20 ± 0.17 mg/g liver), and --2.5 times over cholestanol feeding. The amount of cholestanol per gram of liver did not differ from control.
In this table are also listed the proportions of free and esterified sterols following each dietary regimen. In the control animals, 70% of the cholesterol and 75% of the cholestanol was in the free form. During cholestanol feeding the percentage of esterified cholesterol and cholestanol increased by 5-6% despite the large increase in cholestanol concentration. As expected, during cholesterol feeding 84% of the cholesterol was the large intake of cholestanol, the increment amounted to only 0.58 mg/dl. Biliary sterol concentration (Table III) did not increase despite the marked rise in hepatic sterol levels during the experimental feeding period (Table I ). However, there was an almost fourfold increase in the percent of cholestanol in the biliary sterols after its feeding.
Biliary bile acid composition. The effect of either cholestanol or cholesterol feeding on biliary bile acid composition is shown in Fig. 2 . In the control rats, cholic acid constituted 77% of the biliary bile acids, chenodeoxycholic acid 14%, the muricholic acids 9%, and there were no detectable allo-bile acids. After cholesterol feeding there was no significant difference in biliary bile acid composition. However, when cholestanol was fed there was an increased formation and excretion of allocholic acid (16%) and allochenodeoxycholic acid (5%), the respective 5a-saturated bile acids. These allo-bile acids are produced from cholestanol (26) , and their increased formation probably reflects the large hepatic pool of cholestanol. The rate-controlling enzymes of cholesterol and bile acid biosynthesis. In Table IV are shown the specific activities of hepatic HMG-CoA reductase. As expected, during cholesterol feeding there was a fivefold drop in the activity of HMG-CoA reductase as compared with the control group. In contrast, during cholestanol feeding, HMG-CoA reductase activity increased 2.6-fold as compared with the control values, and was 13 times higher than HMG-CoA reductase activity during cholesterol feeding. These results suggest that the absorbed cholestanol might stimulate hepatic HMG-CoA reductase activity, and unlike cholesterol, does not exert feedback inhibition on this rate controlling enzyme.
It is noteworthy that microsomal cholesterol levels fell by 8% when cholestanol was fed, and although there was a small increase in microsomal cholestanol content, total sterol values did not differ significantly from those of the control values. In contrast, cholesterol feeding led to a substantial rise in microsomal cholesterol content. Thus, the inhibition of hepatic HMG-CoA reductase activity may be modulated through the concentration of microsomal cholesterol.
As to cholesterol 7a-hydroxylase (Table V) , neither cholestanol nor cholesterol feeding affected the activity of this key rate controlling enzyme. It is important to note that these measurements of cholesterol 7a-hydroxylase activity were made with acetone treated microsomal preparations in which the endogenous sterols are completely removed (19) . The sterol content of the acetone powder prepared from hepatic microsomes of rats treated with cholestanol or cholesterol was similar to that of rats fed the control diet, and was as low as 0.38-0.43 nmol/mg of protein, although the sterol content of the different microsomal preparations varied (Table IV) . Fecal sterols. During cholestanol feeding, this 5a-dihydro derivative of cholesterol was the major stanol excreted in the feces (Table VI) , which is consistent with its reduced intestinal absorption (Table II) . Of interest is the increased excretion of cholesterol and its bacterial metabolite, coprostanol, which was 2.5 times greater than that excreted in the control rats, 22.8 vs. 9.1 mg/d, respectively. This observation indicates that cholestanol interfered with cholesterol absorption and is consistent with the results in Table II . During cholesterol feeding, this sterol was the predominant one in the feces, but the quantity of the excreted cholesterol and coprostanol (165.4 mg/d) was smaller than that of cholestanol (230.1 mg/d) when it was fed. This finding is additional evidence that cholesterol was more efficiently absorbed than cholestanol. Furthermore, more bile acids were excreted following cholesterol feeding than after cholestanol or control periods. Histologic findings. Light microscopic examination of liver sections taken from rats given either cholestanol or cholesterol appeared quite normal. However, electron microscopic examination of the same livers depicted some but nondeleterious alterations in the hepatocytic organelles.
In cholestanol-fed rats, hepatocytes of the periportal areas (zone 1 of Rappaport) appeared normal, with mild increase in 
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Metabolism of Cholesterol in the Rat the smooth endoplasmic reticulum (Fig. 3) . In contrast, a marked increase of the vesicles of this organelle (Fig. 4) was observed in hepatocytes of the central areas of the hepatic lobule (zone III of Rappaport), which indicates higher activity of the biotransformation enzyme systems.
On the other hand, the livers of rats fed cholesterol revealed less response of the smooth endoplasmic reticulum, which appeared normal in hepatocytes of the periportal areas (Fig.  5 ) and more vesicular, and moderately increased in the centrilobular hepatocytes (Fig. 6) . The Golgi vesicles often appeared dilated, and mild fatty infiltration was frequently noted (Fig.  5) . Some of the centrilobular hepatocytes revealed a significant increase in the peroxisomes, a phenomenon often seen in increased bile acid metabolism (Fig. 6 ).
Discussion
The results of this investigation show a number of differences in the metabolism of cholesterol and cholestanol in the rat. Both are absorbed, as evidenced by the rise in hepatic sterol concentration (Table I) , and by the measurements of intestinal absorption (Table II) . However, cholesterol was more readily absorbed than cholestanol, 44.8 vs. 14.0%, respectively. This was reflected by the nearly fourfold increase in hepatic sterol content after cholesterol administration, whereas the administration of the same amount of cholestanol resulted in only 48% increase (Table I) . Furthermore, the 24 h-fecal excretion data (Table VI) reflect the same differential absorption. A significantly smaller fraction of the dietary sterol was excreted in the feces following cholesterol feeding (165.4 mg/d) than that after cholestanol feeding (230.1 mg/d). Thus, the intestinal transport system appears to recognize the structural difference between the two compounds. Moreover, the 2.5-fold increase in the excretion of endogenous cholesterol above control (22.8 vs. 9.1 mg/d, respectively) brought about by exogenous cholestanol suggests that the dietary stanol competes favorably for the active absorption mechanism in the intestine.
Current theory states that the rate limiting step for sterol transport is esterification with long chain fatty acid residues. Perhaps cholestanol is a less suitable substrate for intestinal acyl CoA:cholesterol acyltransferase, and as a consequence would slow the entire process of esterification and thereby transport of cholesterol by the intestine. It might also be pointed out that hepatic esterification was much less efficient for cholestanol in contrast to cholesterol (Table I; 31.3 vs. 83.9%, respectively), despite the enhanced sterol absorption noted during both feeding regimens.
It is noteworthy that total sterol levels in bile and serum remained unchanged (Table III) . However, the relative proportion of cholestanol in both fluids was significantly elevated.
Biliary bile acid composition was also different during cholestanol administration. A portion of the cholestanol was converted to allocholic acid (16%) and allochenodeoxycholic acid (5%), as illustrated in Fig. 2 tanol, the 5a-saturated isomer of cholesterol, could be 7a-hydroxylated (27) and transformed by the hepatic enzymes that normally convert cholesterol to bile acids. Alternatively, it is conceivable that separate pathways were involved in the transformation of cholestanol to allo-bile acids (5) . Cholesterol 7a-hydroxylase, which is the rate determining enzyme for bile acid synthesis, was not affected by cholesterol or cholestanol feeding (Table V) . Although it has been shown that total bile acid synthesis as measured by the sterol balance method increases during cholesterol feeding (8) , and indeed similar results were observed in the present study (Table VI) , this increase does not result from de novo enzyme synthesis. However, the increase in bile acid synthesis associated with cholesterol feeding may rather reflect greater availability of the substrate for cholesterol 7a-hydroxylase (19) .
It is important to note that the assay used for measuring cholesterol 7a-hydroxylase activity has been improved. A virtually sterol free microsomal preparation (Table V) which contains the active enzyme was used (19) . Thus, the results are not confounded by the dilution of the ratioactive exogenous substrate.
The most remarkable observation was the nearly threefold rise in HMG-CoA reductase activity when the diet was supplemented by cholestanol. According to current concepts, cholesterol transported in chylomicron remnants is taken up by the liver and exerts feedback inhibition on HMG-CoA reductase, thereby controlling the endogenous synthesis of cholesterol (28) . As expected, when large amounts of cholesterol were fed, HMG-CoA reductase activity declined fivefold (Table  IV) , supporting this hypothesis. In contrast, when cholestanol was administered, HMG-CoA reductase activity levels rose significantly despite the almost 50% increase in hepatic total sterol concentration ( Table 1) . As expected, microsomal cholesterol levels increased 40% during cholesterol feeding, which is probably responsible for the feedback inhibition of HMGCoA reductase activity. When cholestanol was fed, microsomal cholesterol content declined -8%, which was not statistically significant, without any compensatory increase in cholestanol content. It is possible that the slight increase in microsomal cholestanol concentration could have contributed to the activation of HMG-CoA reductase.
Feeding cholestanol or cholesterol to rats, at least for a short period such as 2 wk, appears to have no serious impact on the morphologic structure of the hepatic cells. However, as illustrated in Fig. 4 , there was a marked increase in the smooth endoplasmic reticulum of the centrilobular area of the hepatocytes of the cholestanol fed rats. This change may reflect the activation of HMG-CoA reductase that was noted during cholestanol feeding. These results may have some relevance to the pathogenesis of sterol deposits in the rare inherited lipid storage disease cerebrotendinous xanthomatosis. In this disease, large amounts 1780 of cholestanol are deposited in various tissues associated with enhanced cholesterol synthesis (3). It is conceivable that the accumulation of cholestanol in the liver and tissues of patients with this disease may lead to activation of cholesterol synthesis.
In summary, the present study shows that: (a) cholestanol is absorbed and deposited in the liver; (b) cholestanol competes and reduces cholesterol absorption; and (c) cholestanol feeding is associated with a marked increase in the smooth endoplasmic reticulum of the centrilobular area and leads to the derepression of cholesterol biosynthesis. Thus, despite the structural similarity of cholestanol and cholesterol, considerable biochemical differences exist.
